Physician profile
Colby Ricks
NPI 1114302064
$6,263.18
in general payments reported to CMS, 2019-2025
14 companies · $898 in 2025
The $898 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $447 · 2021: $944 · 2022: $1,133 · 2023: $1,090 · 2024: $1,017 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,567 · Entertainment: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,566.51 |
| Entertainment | $437.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,679.82 | 2019-2025 | Precision 1, Dailies, Total30 |
| Optos, INC. | $609.54 | 2021-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $497.30 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $291.55 | 2019 | |
| Bausch & Lomb Americas INC. | $246.63 | 2022-2025 | Biotrue One Day, Infuse |
| Sight Sciences, INC. | $148.28 | 2022-2025 | Tearcare System |
| Lkc Technologies, INC. | $140.47 | 2024-2025 | |
| Ocular Therapeutix, INC. | $125.63 | 2022 | |
| Rxsight INC | $119.62 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Vision Care, INC. | $114.29 | 2019-2021 | |
| Allergan, INC. | $100.43 | 2019-2022 | |
| Abbvie INC. | $98.20 | 2022-2023 | |
| Lombart Brothers, INC. | $72.02 | 2023-2025 | Opd-III |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colby Ricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.